More articles from Myeloproliferative Disorders

Clonal independence of JAK2 and CALR or MPL mutations in co-mutated myeloproliferative neoplasms demonstrated by single cell DNA sequencing
Ella R. Thompson, Tamia Nguyen, Yamuna Kankanige, Paul Yeh, Michael Ingbritsen, Michelle McBean, Timothy Semple, Gisela Mir Arnau, Kate Burbury, Nora Lee, Amit Khot, David Westerman, Piers Blombery

Haematologica Aug 2020, haematol.2020.260448; DOI: 10.3324/haematol.2020.260448
Altered T-cell subset repertoire affects treatment outcome of patients with myelofibrosis
Ivo Veletic, Sanja Prijic, Taghi Manshouri, Graciela M. Nogueras-Gonzalez, Srdan Verstovsek, Zeev Estrov

Haematologica Jul 2020, haematol.2020.249441; DOI: 10.3324/haematol.2020.249441
Dynamics of mutations in patients with essential thrombocythemia treated with imetelstat
Elisabeth Oppliger Leibundgut, Monika Haubitz, Bart Burington, Oliver G. Ottmann, Gary Spitzer, Olatoyosi Odenike, Michael A. McDevitt, Alexander Röth, David S. Snyder, Gabriela M. Baerlocher

Haematologica Jul 2020, haematol.2020.252817; DOI: 10.3324/haematol.2020.252817
Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis
Fredrik H. Schjesvold, Paul G. Richardson, Thierry Facon, Adrián Alegre, Andrew Spencer, Artur Jurczyszyn, Kazutaka Sunami, Laurent Frenzel, Chang-Ki Min, Sophie Guillonneau, Peggy L. Lin, Solenn Le-Guennec, Frank Campana, Helgi van de Velde, Samira Bensfia, Sara Bringhen

Haematologica Jun 2020, haematol.2020.253450; DOI: 10.3324/haematol.2020.253450
Concomitant constitutive LNK and NFE2 mutation with loss of sumoylation in a case of hereditary thrombocythemia
Lukas Clemens Böckelmann, Titiksha Basu, Albert Gründer, Wei Wang, Jan Breucker, Sandra Kaiser, Andrea Pichler, Heike Luise Pahl

Haematologica Jun 2020, haematol.2020.246587; DOI: 10.3324/haematol.2020.246587
CCND2 mutations are infrequent events in BCR-ABL1 negative myeloproliferative neoplasm patients
Bruno Cassinat, Emmanuelle Verger, Nabih Maslah, Nicolas Gauthier, William Vainchenker, Stéphane Giraudier, Jean-Jacques Kiladjian

Haematologica May 2020, haematol.2020.252643; DOI: 10.3324/haematol.2020.252643
Down syndrome-related transient abnormal myelopoiesis is attributed to a specific erythro-megakaryocytic subpopulation with GATA1 mutation
Yoko Nishinaka-Arai, Akira Niwa, Shiori Matsuo, Yasuhiro Kazuki, Yuwna Yakura, Takehiko Hiroma, Tsutomu Toki, Tetsushi Sakuma, Takashi Yamamoto, Etsuro Ito, Mitsuo Oshimura, Tatsutoshi Nakahata, Megumu K. Saito

Haematologica Apr 2020, haematol.2019.242693; DOI: 10.3324/haematol.2019.242693
Myeloid/lymphoid neoplasms with eosinophilia/ basophilia and ETV6-ABL1 fusion: cell-of-origin and response to tyrosine kinase inhibition
JinJuan Yao, Lianrong Xu, Umut Aypar, Howard J. Meyerson, Dory Londono, Qi Gao, Jeeyeon Baik, James Dietz, Ryma Benayed, Allison Sigler, Mariko Yabe, Ahmet Dogan, Maria E. Arcila, Mikhail Roshal, Yanming Zhang, Michael J. Mauro, Wenbin Xiao

Haematologica Apr 2020, haematol.2020.249649; DOI: 10.3324/haematol.2020.249649
Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study.
Anders Lindholm Sørensen, Stine Ulrik Mikkelsen, Trine Alma Knudsen, Mads Emil Bjørn, Christen Lykkegaard Andersen, Ole Weis Bjerrum, Nana Brochmann, Dustin Andersen Patel, Lise Mette Rahbek Gjerdrum, Daniel El Fassi, Torben A. Kruse, Thomas Stauffer Larsen, Hans Torben Mourits-Andersen, Claus Henrik Nielsen, Christina Ellervik, Niels Pallisgaard, Mads Thomassen, Lasse Kjær, Vibe Skov, Hans Carl Hasselbalch

Haematologica Jan 2020, haematol.2019.235648; DOI: 10.3324/haematol.2019.235648
Mixed myeloid chimerism and relapse of myelofibrosis after allogeneic stem cell transplantation
Samer A. Srour, Amanda Olson, Stefan O. Ciurea, Parth Desai, Qaiser Bashir, Betul Oran, Prithviraj Bose, Rohtesh Mehta, Keyur P. Patel, Naveen Pemmaraju, Naval Daver, Srdan Verstovsek, Richard E. Champlin, Uday R. Popat

Haematologica Jul 2019, haematol.2019.223503; DOI: 10.3324/haematol.2019.223503

More articles from Myeloproliferative Disorders

Pages